摘要
中国是食管癌的高发地区。对于不可切除局部进展期食管癌,如何进一步增加治愈机会并提高远期生存,是国内外肿瘤医师共同关注的临床难题。近年来越来越多的临床研究在同步放化疗、诱导化疗及其后续治疗等治疗方面进行探索,本文主要对不可切除胸段局部进展期食管鳞癌提出的治疗策略予以阐述和比较,以期为临床实践中的选择提供依据。
There is a high incidence of esophageal cancer in China.Unresectable locally advanced thoracic esophageal carcinoma are very lethal diseases.To further increase the disease control and improve the survival based on multidisciplinary treatment are great challenges to the oncologists all over the world.Recently,an increasing number of clinical trials are reported focusing on concurrent chemo radiotherapy,induction chemotherapy and subsequent treatment.This article reviewed the strategies of treatment for unresectable locally advanced thoracic esophageal squamous carcinoma,to provide reasonable evidence for wise option for treatment of this disease.
作者
张敬南
种晓艺
杨宏
张小田
ZHANG Jing-nan;CHONG Xiao-yi;YANG Hong;ZHANG Xiao-tian(Department of Gastrointestinal Oncology,Peking University Cancer Hospital & Institute,Beijing 100142,China;Department of Oncology Surgery,Sun Yat Sen University Cancer Center,Guangzhou 510060,China)
出处
《肿瘤综合治疗电子杂志》
2019年第3期18-24,共7页
Journal of Multidisciplinary Cancer Management(Electronic Version)
基金
北京市医院管理局2018年消化合作研究计划(XXT19)
关键词
不可切除
局部进展期
胸段食管鳞癌
放化疗
手术
多学科诊治
Unresectable
Stage of locally advanced
Thoracic esophageal squamous carcinoma
Chemo radiotherapy
Surgery
Multidisciplinary team(MDT)